These results, together with a preceding report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the concept of concentrating on ACKR3 as a unique way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-associated disorders. At that time, Microsoft Marketing https://tonyg516gwn1.blogolenta.com/profile